+91-8668442535

Veterinary Biologics Market By Product (Vaccines, Diagnostic Kits, Nutritional and Hormonal Supplement, Allergenic Extract and Others), By Type (Production Animal and Companion Animal) - Growth, Future Prospects & Competitive Analysis, 2018 - 2026

The veterinary biologics market is set to reach from US$ 17,704.7 Mn in 2017 to US$ 29,706.9 Mn by 2026 at a compound annual growth rate (CAGR) of 6.0% during the forecast period from 2018 to 2026. Veterinary biologics are medicinal products obtained from living organism and biological processes. They are employed in veterinary health science to diagnose, prevent and treat animal disease through immune-modulation. According to United States Department of Agriculture (USDA), over the span of 70 years there has been a significant growth in the veterinary biologics market, wherein today approximately 2000 licensed biological products are employed to treat 200 different types of disease in 35 animal species.

Market Synopsis

Veterinary Biologics Market 

Get a sample copy for more information

"Rising prevalence of zoonotic diseases and technological development in vaccine production by recombinant DNA technology drive the vaccines market growth"

Vaccines are currently leading the product segment for veterinary biologics market. The major factors contributing to its culminating growth are rising prevalence of zoonotic disease and technological innovation in veterinary vaccines production employing the recombinant DNA technology. Molecular diagnostic kits holds the second largest market in the products segment on account of increasing prevalence of contagious disease in poultry, bovine and porcine animal species. Nutritional and hormonal supplement will be the fastest growing market on account of increasing demand for dairy and meat industry and growing important of probiotics to improve animal feed products quality.

Veterinary Biologics Market 

Get a sample copy for more information

"Proactive government policies focusing on long term sustainable development and improving livestock health drive the production animal market growth"

Currently production animals are reigning the animal type segment pertaining to veterinary biologics market. Proactive government policies throughout the globe are focusing on long term sustainable growth by ensuring total food security and improving livestock healthcare. According to the research findings of Food and Agriculture Organization (FAO), animal based food products accounts for one third of human protein consumption. Rampant growth in dairy industry further propels the production animal market growth. Companion animals will be the fastest growing animal type segment in the near future due to significant growth in pet adoption and stringent government norms for mandatory vaccination of pet animals.

Veterinary Biologics Market 

Get a sample copy for more information

"Existence of highly developed agrobased industry and rampant growth in animal husbandry department drive the market growth in North America"

In the present scenario North America accounts for 40% of the global market share in veterinary biologics market. The key factors responsible for the dominance of North America are presence of highly developed agrobased industry and rapid growth in animal husbandry department. Rising public animal health awareness and significant growth in pet adoption further fortify the veterinary biologics market growth in North America. Europe represents 31% market share and is the second largest regional segment for veterinary biologics market. Increasing growth in dairy and meat industry and stringent regulatory norms imposed by healthcare agencies for compulsory vaccination of animals propels the market growth in European region. Asia Pacific holds 17% market share and will be the fastest growing market during the forecast period from 2018 to 2026. Rising prevalence of zoonotic disease and proactive government policies to financially support veterinary departments consolidate the veterinary biologics market growth in Asia Pacific region. Latin America and Middle East & Africa serve as a potential market for major players to promote business expansion and capture the untapped market in rural areas.

Veterinary Biologics Market

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.

Veterinary Biologics Market 

Report Scope by Segments

The market segmentation comprises of by product, type and geography.

ATTRIBUTE DETAILS
Research Period  2016-2026
Base Year 2017
Forecast Period  2018-2026
Historical Year  2016
Unit  USD Million
Segmentation

 By Product (2016–2026; US$ Mn)
 • Vaccines
 • Diagnostic Kits
 • Nutritional and Hormonal Supplement
 • Allergenic Extract
 • Others 

 By Type (2016–2026; US$ Mn)
 • Production Animal
 • Companion Animal

 Geography Segment (2016–2026; US$ Mn)
 • North America (United States and Canada)
 • Europe (U.K., Germany, Rest of Europe)
 • Asia Pacific (China, Japan, Rest of Asia Pacific)
 • Latin America (Brazil, Mexico, Rest of Latin America)
 • Middle East and Africa (GCC, Rest of MEA)

Biopharmaceutical companies actively participating in veterinary biologics market are Boehringer Ingelheim Animal Health GmbH, Ceva Sante Animale, Evonik Industries AG, Heska Corporation, Intervet, Inc., INDICAL Bioscience, IDEXX Laboratories, Inc., Virbac, Inc., VCA, Inc. and Zoetis.

Key questions answered in this report

  • Who are the major biopharmaceutical companies actively participating in veterinary biologics market?
  • How is the market assessment performed and what are the latest market trends prevalent in veterinary biologics market?
  • What are veterinary biologics and how do they impact animal health?
  • What will be the market size and CAGR for veterinary vaccines market during the forecast period 2018 to 2026?
  • What factors are responsible for the dominance of companion animal market growth?
  • What will be the performance of Asia Pacific region in the near future?
Choose License Type
Budget Buying
Executive Summary - Brief Global Market Size - Current & Forecast
Regional Market Size - North America
Country Market Size - US
Company Profile – 1
Trusted By
Godaddy
Published Date:  Jan 2019
Category:  Pharmaceuticals
Report ID:   59540
Report Format:   PDF
Pages:   120
Rating:    4.2 (56)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support